# Volta Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/volta-labs

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.voltalabs.com
- Total disclosed funding: $25M
- Latest round: Series A (Jan 27, 2022)
- Investors on record: 7

## About

Based in Massachusetts, US, and founded in 2018 by its CEO, Udayan Umapathi, and co-founder Will Langford, Volta Labs, Inc. operates as a biotechnology company that develops solutions to streamline the upstream workflows in genomic sequencing. In March 2022, Volta Labs, Inc. raised USD 20 million in series A funding led by new investor Maverick Ventures, with participation from other new investors Khosla Ventures, Casdin Capital, E14 Funds, Blindspot Ventures, and several individual investors.

Volta Labs, Inc. develops a sequencing technology-agnostic platform that spans from the raw biological sample to sequenceable molecules. The company is reinventing the full-stack hardware, software, chemistry, and biology to create solutions for sample preparation. Its platform integrates components from the electronics, automation, and materials industries with a software stack.

The company will use the series A funding to advance the development of a sequencer-agnostic front-end platform for commercial release in 2023.

## Funding rounds

- Series A, Jan 27, 2022, $25M — Khosla Ventures, Maverick Capital, Casdin Capital, E14 Fund, Blindspot Ventures
- Seed, Mar 22, 2019 — Y Combinator, Acequia Capital

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Acequia Capital (https://capitalatlas.ai/funds/acequia-capital) — Seed
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Maverick Capital (https://capitalatlas.ai/funds/maverick-capital) — Series A
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A
- E14 Fund (https://capitalatlas.ai/funds/e14-fund) — Series A
- Blindspot Ventures (https://capitalatlas.ai/funds/blindspot-ventures) — Series A